26 June 2020 : Clinical Research
Hepatitis B Surface Antigen (HBsAg) Kinetics in Chronic Hepatitis B Patients during Peginterferon Treatment
Kaifa Wang1AEG, Guangyu Huang2BCF*, Yagang Chen2DF, Yuming Wang34BFDOI: 10.12659/MSM.921487
Med Sci Monit 2020; 26:e921487
Table 1 Basic information of functionally cured patients.
| ID | Gender | Age (years) | Baseline HBsAg (IU/mL) | Treatment duration (days) |
|---|---|---|---|---|
| 467029 | Male | 53 | 3.4 | 88 |
| 492622 | Male | 40 | 0.1 | 49 |
| 24386 | Male | 37 | 1.36 | 49 |
| 76908 | Male | 34 | 2.12 | 97 |
| 414394 | Male | 34 | 0.17 | 42 |
| 80144 | Male | 35 | 0.53 | 108 |
| 474914 | Male | 44 | 34.65 | 91 |
| 267849 | Male | 34 | 263.82 | 126 |
| 103232 | Male | 34 | 338.72 | 121 |
| 271387 | Female | 30 | 490.31 | 167 |
| 495742 | Male | 32 | 59.31 | 91 |
| 243776 | Female | 33 | 82.9 | 147 |
| 56338 | Male | 34 | 550.0 | 77 |